Horizon Inks $660M Deal For Specialty Drugmaker
Horizon Pharma Inc. said Wednesday it would pick up Ireland's Vidara Therapeutics International Ltd. in a cash-and-stock transaction worth $660 million, expanding the Illinois-based pharmaceutical company's portfolio of medications marketed in...To view the full article, register now.
Already a subscriber? Click here to view full article